Cargando…
COVID-19 and off label use of drugs: an ethical viewpoint
BACKGROUND: The COVID-19 outbreak is rapidly spread over the world and kills infected patients. There is no proven medication for its treatment, so, all of the medications used for treatment are considered to be off-label. Off-label uses are not under regulation in the outbreak because there is no s...
Autores principales: | Shojaei, Amirahmad, Salari, Pooneh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207985/ https://www.ncbi.nlm.nih.gov/pubmed/32385829 http://dx.doi.org/10.1007/s40199-020-00351-y |
Ejemplares similares
-
COVID-19 and the “Stay at home” recommendation: An ethnographic study
por: Shojaei, Amirahmad, et al.
Publicado: (2021) -
Trust-building in the Pharmacist-patient Relationship: A Qualitative Study
por: Esmalipour, Rasool, et al.
Publicado: (2021) -
Ethical review of off-label drugs during the COVID-19 pandemic
por: Li, Qiu-Yu, et al.
Publicado: (2022) -
The Ethics of Using Off-Label Medications to Treat COVID-19
por: Huffman, Alan
Publicado: (2022) -
To Tell, or Not to Tell; Confidentiality in an Iranian HIV Positive Patient: A Viewpoint
por: Noroozi, Mahshad, et al.
Publicado: (2017)